Allergen immunotherapy is one of the few disease-modifying treatments available in outpatient medicine—but its effectiveness depends entirely on patients completing a precisely sequenced build-up protocol over months, followed by years of maintenance therapy. A missed injection appointment is not just a scheduling inconvenience; depending on the gap, it requires dose reduction or protocol restart. Managing the scheduling, recall, and prior authorization infrastructure that keeps hundreds of immunotherapy patients on track is one of the most administratively intensive functions in an allergy and immunology practice—and an ideal domain for a trained virtual assistant (VA).
Build-Up Schedule Management
The subcutaneous immunotherapy (SCIT) build-up phase typically involves one to two injections per week for three to six months, with dose increments following a specific protocol for each patient's allergen extract vial. Tracking where each patient is in their build-up sequence—which vial, which dose, which visit interval—and scheduling future appointments at the correct interval requires systematic documentation and proactive scheduling management.
Virtual assistants maintain build-up calendars for each active immunotherapy patient, scheduling future injection appointments at the protocol-specified intervals immediately after each visit is completed. When a patient needs to reschedule, the VA ensures the new appointment falls within the acceptable dose-hold window for their current protocol level. Patients who are approaching a dose advancement milestone are flagged for nursing staff review before their next appointment.
According to the American Academy of Allergy, Asthma and Immunology (AAAAI), patients who experience administrative barriers to scheduling—including difficulty reaching the practice to schedule or waiting too long for a next available appointment—are significantly more likely to drop out of immunotherapy before completing build-up. VAs who proactively book the next appointment at checkout eliminate this barrier entirely.
Shot Recall and Patient Re-Engagement
Patients who miss immunotherapy appointments and do not reschedule within the dose-hold window will lapse from their current protocol level—requiring a step-back in dose or a protocol restart. Without active recall, these lapses accumulate silently until the patient either returns on their own or abandons treatment. Proactive recall outreach—contacting patients who have missed appointments before the dose-hold window closes—is the most effective intervention, but it requires consistent execution that busy nursing staff rarely have time to provide.
Virtual assistants own the recall cycle: generating daily or weekly missed-appointment reports from the practice management system, contacting patients via their preferred channel (call, text, or portal message), confirming the reason for the missed appointment, and scheduling a make-up visit within the acceptable window. For patients who have exceeded the dose-hold window, the VA notifies the allergist and schedules a reassessment appointment to determine the appropriate re-entry dose.
A 2024 study published in the Annals of Allergy, Asthma and Immunology found that practices with active immunotherapy recall programs had build-up completion rates 35% higher than practices relying on patient-initiated rescheduling. A VA managing this recall program is a direct contributor to clinical outcomes.
Prior Authorization for Allergen Extracts and Biologics
Allergen immunotherapy extracts require prior authorization from most payers, typically renewed annually. Biologics used in allergy and immunology practice—dupilumab, omalizumab, benralizumab—require more complex prior authorization with step therapy documentation and periodic renewal. Managing these authorization cycles for a practice with hundreds of immunotherapy patients and dozens of biologic prescriptions is a continuous administrative workload.
Virtual assistants manage the prior authorization calendar, initiating renewal requests 60 days before each authorization expiration, submitting through payer-specific portals or fax channels, tracking approval status, and escalating peer-to-peer review requests when authorizations are denied. For biologic prior auths, the VA prepares the clinical documentation package—including diagnosis documentation, prior therapy history, and step therapy documentation—for physician review before submission.
A 2025 report by the AAAAI noted that administrative burden from prior authorization management is among the top three sources of physician burnout in allergy and immunology practice. VAs taking ownership of the authorization cycle reduce this burden measurably without requiring any clinical judgment from the VA.
Maintenance Phase Scheduling and Annual Vial Reorder
Once a patient reaches maintenance dose, injection intervals extend to monthly or less frequent visits. Managing maintenance schedules—ensuring patients receive injections on schedule and that their allergen extract vials are reordered before expiration—requires ongoing administrative tracking that is easy to deprioritize when clinical staff are focused on build-up patients.
Virtual assistants maintain maintenance patient calendars, scheduling annual maintenance visits at the protocol-specified intervals and generating vial reorder alerts when extract vials are approaching their expiration date. They coordinate with the compounding pharmacy or extract preparation service to ensure reorders are placed with sufficient lead time to avoid treatment gaps.
Building a VA-Supported Allergy Practice
Allergy practices with active immunotherapy programs typically find that one trained VA can manage build-up scheduling, recall, and prior authorizations for 150 to 250 active immunotherapy patients, with additional capacity for biologic authorization management. Practices with higher patient volumes benefit from dedicated VAs for scheduling and recall versus authorization management.
Stealth Agents provides VAs with allergy and immunology administrative training, experienced in immunotherapy scheduling, AAAAI-compliant documentation workflows, and biologic prior authorization portals.
Sources
- American Academy of Allergy, Asthma and Immunology (AAAAI), "Immunotherapy Administration and Practice Operations Survey," 2025
- Annals of Allergy, Asthma and Immunology, "Recall Programs and Immunotherapy Completion Rates," 2024
- AAAAI, "Prior Authorization Burden in Allergy and Immunology Practice," 2025